Programme

Go directly to a day's programme
Thursday | Friday | Saturday

 

 

Wednesday 25 January 2012

 

08.30 – 18.00      Pre-Meeting Workshop

                          Masterclass in the management of chronic and allergic pulmonary aspergillosis

                          Open to 35 clinicians

                          Lead by Professor David Denning and other colleagues.

 

Please click here for more information

 

 

Thursday 26 January 2012 – Day 1

 

08.00 – 08.45      Meet the Professor Session

                          Controversies in immunology: Excessive inflammation in aspergillosis

                          Luigina Romani, MD, PhD

 

09.00 – 09.10      Opening Remarks

                          William J. Steinbach, MD

 

 

Session 1: Cutting Issues in the Pathogenesis of Aspergillosis
Chairs: William J. Steinbach, MD & Jean-Paul Latgé, PhD

 

09.15 – 09.40      Angiogenesis at the mold-host interface: a potential key to understanding and treating invasive aspergillosis

                          Ronen Ben-Ami, MD

 

09.40 – 10.05      Aspergillus fumigatus survival in the lung environment

                          Elaine Bignell, PhD

 

10.05 – 10.30      Visualising phagosomal killing of Aspergillus fumigatus

                          Jatin M. Vyas, MD

 

10.30 – 10.55      Vitamin D and OX40L interaction

                          Jay K. Kolls, MD

 

10.55 – 11.05      Oral Poster Presentation: Aspergillus fumigatus supermaters: genome comparison and genetic recombination
Janyce Sugui, PhD

 

 

11.05 – 11.35      Coffee / Tea Break

 

 

Session 2: Emerging Clinical Associations with Aspergillosis
Chairs: David W. Denning, FMedSci & Omrum Uzun, MD

 

11.35 – 12.00      COPD and aspergillosis

                          Jesús V. Guinea Ortega, PharmD, PhD

 

12.00 – 12.25      Aspergillosis in cystic fibrosis – insights from new and old diagnostics

                          Caroline Baxter, MD

 

12.25 – 12.50      Invasive aspergillosis in ICU – are we moving forward?

                          George Dimopoulos, MD

 

12.50 – 13.15      Immune regulation in idiopathic bronchiectasis

                          Rosemary Boyton, PhD

 

 

13.15 – 14.45      Lunch

 

 

Session 3: Top Six Papers in Aspergillosis in 2011
Chair: Sevtap Arikan-Akdagli, MD & Jay K. Kolls, MD

 

13.45 – 14.45 and concurrent with lunch

Murat Akova, MD and Nir Osherov, PhD

 

 

Session 4: Novel Immunological Insights into Aspergillosis
Chairs: Richard B. Moss, MD & Emmanuel Roilides, MD

 

14.45 – 15.10      Innate immunity to Aspergillus

                          Mihai G. Netea, PhD

 

15.10 – 15.35      Neutrophil extracellular traps and A. fumigatus

                          Matthias Gunzer, PhD

 

15.35 – 15.45      Control of neutrophil ROS responses to A. fumigatus

                          Keith Boyle, PhD

 

15.45 – 15.55      Oral Poster Presentation: T-cell responses to several Aspergillus antigens may be detected in patients with invasive Aspergillosis and may be exploited for diagnostic and therapeutic purposes: a multicenter study
Leonardo Potenza, MD, PhD

 

 

15.55 – 16.25      Coffee / Tea Break

 

 

Session 5: Portraits of Non-Fumigatus Aspergilli – What is so Special About:
Chairs: Paul Bowyer, PhD & Karl V. Clemons, PhD

 

16.25 – 16.50      Specification of polarity sites during growth and development of Aspergillus nidulans

                          Steven D. Harris, PhD

 

16.50 – 17.15      Aspergillus niger a perfect host for industrial biotechnology: systems biology approaches for the production of building block chemicals

                          Peter J. Punt, PhD

 

17.15 – 17.40      Diversity of Aspergillus flavus on crops and in the environment can be exploited to reduce aflatoxin exposure and improve environmental health

                          Peter J. Cotty, PhD

 

17.40 – 17.50      Oral Poster Presentation: Unique polysaccharide cell-wall composition responsible for dysregulated inflammation of A. nidulans infections in chronic granulomatous disease
Stefanie Henriet, MD

 

 

17.50 – 19.50      Welcome Reception, Drinks and Poster Session 1

 

Dinner (on your own)

 

 

Friday 27 January 2012 – Day 2   [back to top of page]

 

Session 6: Astellas Symposium
Chair: Katsuhiko Kamei, MD, PhD

 

08.00 – 09.00      Controversies in management: prophylaxis or diagnostics

                          Andrew Ullman, MD

                          Drosos E. Karageorgopoulos, MD

 

 

Session 7: Genomics and Proteomics
Chairs: Elaine Bignell, PhD & David S. Perlin, PhD

 

09.15 – 09.40      Aspergillus adhesions

                          Don Sheppard, MD

 

09.40 – 10.05      mRNAs in Aspergillus

                          Michelle Momany, PhD

 

10.05 – 10.30      RNAseq

                          Antonis Rokas, PhD

 

10.30 – 10.55      Alternative approaches to drug discovery in Aspergillus fumigatus

                          Michael Bromley, PhD

 

10.55 – 11.20      Targets for broad spectrum antifungal vaccines? Quantitative proteomic comparisons of Aspergillus & Co.

                          Markus Kalkum, PhD

 

 

11.20 – 11.50      Coffee / Tea Break

 

 

Session 8: Management of Aspergillosis
Chairs: John E. Bennett, MD & Volkan Korten, MD

 

11.50 – 12.15      Management of chronic pulmonary aspergillosis

                          Koichi Izumikawa, MD, PhD

 

12.15 – 12.40      Update on biologicals for ABPA and asthma

                          Richard B. Moss, MD

 

12.40 – 13.05      Paediatric aspergillosis

                          Andreas Groll, MD

 

13.05 – 13.15      Aspergillus bronchitis in non-immunocompromised patients – case series, response to treatment and criteria for diagnosis Timothy Felton, MD

 

 

13.15 – 14.15      Lunch

 

 

14.15                  CONFERENCE SOCIAL EVENT: Tours followed by Dinner

 


 

Saturday 28 January 2012 – Day 3   [back to top of page]

 

08.00 – 08.45      Meet the Professor

                          Stump the Professor – Interesting clinical dilemmas

                          John E. Bennett, MD

                          Souha Kanj, MD

 

 

Session 9: Diagnostics and Imaging
Chairs: Dimitrios P. Kontoyiannis, MD & Malcolm Richardson, PhD

 

09.15 – 09.40      Application of diagnostic markers for IA in children

                          Emmanuel Roilides, MD

 

09.40 – 10.05      Impact of prophylaxis on galactomannan, beta-D-glucan and PCR

                          J. Peter Donnelly, PhD

 

10.05 – 10.30      Which antigens are important and why?

                          Max S. Topp, MD

 

10.30 – 10.40      Oral Poster Presentation: Impact of current antifungal therapy on PCR based investigation of bronchoalveolar lavage samples for diagnosing pulmonary aspergillosis in patients with hematologic malignancies
Mark Reinwald, MD

 

 

10.40 – 11.10      Coffee / Tea Break

 

 

Session 10: Pfizer Symposium
The Treatment Options Strategies for IA
Chairman: J. Peter Donnelly, PhD

 

11.10 – 11.15      Welcome and introduction

                          J. Peter Donnelly, PhD

 

11.15 – 11.30      Stratification of risk for IA in immunocompromised patients

                          Raoul Herbrecht, MD

 

11.20 – 11.45      Pre-emptive versus empirical anti-fungal therapy in neutropenic hematologic patients

                          Omrum Uzun, MD

 

11.45 – 12.00      Combination therapy: who benefits?

                          Keiren Marr, MD

 

12.00 – 12.10      Panel discussion

 

 

12.10 – 14.10      Lunch and Poster Session 2

 

 

Session 11: Antifungal Resistance
Chairs: David A. Stevens, MD & Beyza Ener, MD

 

14.10 – 14.35      Global status of azole resistance in Europe and Asia

                          Sevtap Arikan-Akdagli, MD

 

14.35 – 15.00      Update on resistance mechanisms

                          David S. Perlin, PhD

 

15.00 – 15.10      Oral Poster Presentation: Aspergillus fumigatus biofilms releases extracellular DNA which plays a role in phase dependant antifungal resistance

                          Ranjith Rajendran, MSc

 

15.10 – 15.35      Current section and species complex concepts: recommendations for routine daily practice

                          Manuel Cuenca-Estrella, MD, PhD

 

15.35 – 16.00      Implications of resistance in Aspergillus treatment guidelines

                          Dimitrios P. Kontoyiannis, MD

 



16.00 – 16.10      Farewell

                          David A. Stevens, MD

 

16.20                  Farewell Drinks and Discussion about the next AAA Meeting

 

 

Dinner (on your own)

 

 

Istanbul

 

Istanbul